Crohn's Disease
The Crohn's Disease pipeline: 68 tracked drugs, 36 approved for this indication.
36 approved / phase 47 Phase 31 Phase 2/310 Phase 23 Phase 1/210 Phase 11 preclinical / unstaged
Compare the share prices of listed companies in Crohn's Disease →
Total attributable cost
$17.7B
$17,463/patient
Drug spend
Not yet sourced
All severities · US
The Crohn's Disease pipeline
Key trial results for every approved and late-stage drug: Crohn's Disease results by drug.